# Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis Subjects

Study · id `cardio:ct-nct04707768` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04707768](<https://clinicaltrials.gov/study/NCT04707768>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04707768

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 456 participants.

## Technical summary

Registry record NCT04707768. Randomized; no masking; primary purpose treatment. Start 2021-06-18 (actual); primary completion 2023-01-06 (actual). Results posted on 2025-01-15.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 456 participants (enrolled count; ClinicalTrials.gov record NCT04707768, source copy `cardio:ctgov-nct04707768-2025-01-15`, retrieved 2026-10-26)
- Started: 2021-06-18 (actual) (ClinicalTrials.gov record NCT04707768, source copy `cardio:ctgov-nct04707768-2025-01-15`, retrieved 2026-10-26)
- Primary completion: 2023-01-06 (actual) (ClinicalTrials.gov record NCT04707768, source copy `cardio:ctgov-nct04707768-2025-01-15`, retrieved 2026-10-26)
- Completion: 2023-01-30 (actual) (ClinicalTrials.gov record NCT04707768, source copy `cardio:ctgov-nct04707768-2025-01-15`, retrieved 2026-10-26)
- Results first posted: 2025-01-15 (ClinicalTrials.gov record NCT04707768, source copy `cardio:ctgov-nct04707768-2025-01-15`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04707768, source copy `cardio:ctgov-nct04707768-2025-01-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04707768-2025-01-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis Subjects
- Condition: Anemia Associated With Chronic Kidney Disease (CKD)
- Intervention (Drug): Vadadustat
- Intervention (Drug): Mircera®
- Lead sponsor: Akebia Therapeutics
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Akebia Therapeutics (`cardio:org-akebia-therapeutics`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Vadadustat Three Times Weekly in Patients With Anemia Due to Dialysis-Dependent CKD (`cardio:pubmed-39521398`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: ad569a236c80d6b482c5a7135f878371d523aeb844f80a37fa5a1f5cb297f229
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
